These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 21620714)
21. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation. Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130 [TBL] [Abstract][Full Text] [Related]
22. Poly-thymidine oligonucleotides mediate activation of murine glial cells primarily through TLR7, not TLR8. Du M; Butchi NB; Woods T; Peterson KE PLoS One; 2011; 6(7):e22454. PubMed ID: 21811614 [TBL] [Abstract][Full Text] [Related]
23. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. Kuznik A; Bencina M; Svajger U; Jeras M; Rozman B; Jerala R J Immunol; 2011 Apr; 186(8):4794-804. PubMed ID: 21398612 [TBL] [Abstract][Full Text] [Related]
24. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9. Wang J; Shao Y; Bennett TA; Shankar RA; Wightman PD; Reddy LG J Biol Chem; 2006 Dec; 281(49):37427-34. PubMed ID: 17040905 [TBL] [Abstract][Full Text] [Related]
25. Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist. Nuhn L; Van Hoecke L; Deswarte K; Schepens B; Li Y; Lambrecht BN; De Koker S; David SA; Saelens X; De Geest BG Biomaterials; 2018 Sep; 178():643-651. PubMed ID: 29573820 [TBL] [Abstract][Full Text] [Related]
26. Further hit optimization of 6-(trifluoromethyl)pyrimidin-2-amine based TLR8 modulators: Synthesis, biological evaluation and structure-activity relationships. Dolšak A; Šribar D; Scheffler A; Grabowski M; Švajger U; Gobec S; Holze J; Weindl G; Wolber G; Sova M Eur J Med Chem; 2021 Dec; 225():113809. PubMed ID: 34488023 [TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor-8 agonistic activities in C2, C4, and C8 modified thiazolo[4,5-c]quinolines. Kokatla HP; Yoo E; Salunke DB; Sil D; Ng CF; Balakrishna R; Malladi SS; Fox LM; David SA Org Biomol Chem; 2013 Feb; 11(7):1179-98. PubMed ID: 23314908 [TBL] [Abstract][Full Text] [Related]
28. Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations. Gentile F; Deriu MA; Licandro G; Prunotto A; Danani A; Tuszynski JA Molecules; 2015 May; 20(5):8316-40. PubMed ID: 26007168 [TBL] [Abstract][Full Text] [Related]
29. Potent Lymphatic Translocation and Spatial Control Over Innate Immune Activation by Polymer-Lipid Amphiphile Conjugates of Small-Molecule TLR7/8 Agonists. De Vrieze J; Louage B; Deswarte K; Zhong Z; De Coen R; Van Herck S; Nuhn L; Kaas Frich C; Zelikin AN; Lienenklaus S; Sanders NN; Lambrecht BN; David SA; De Geest BG Angew Chem Int Ed Engl; 2019 Oct; 58(43):15390-15395. PubMed ID: 31397948 [TBL] [Abstract][Full Text] [Related]
30. Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer. Shukla NM; Salunke DB; Balakrishna R; Mutz CA; Malladi SS; David SA PLoS One; 2012; 7(8):e43612. PubMed ID: 22952720 [TBL] [Abstract][Full Text] [Related]
31. A pH-sensitive Macromolecular Prodrug as TLR7/8 Targeting Immune Response Modifier. Aichhorn S; Linhardt A; Halfmann A; Nadlinger M; Kirchberger S; Stadler M; Dillinger B; Distel M; Dohnal A; Teasdale I; Schöfberger W Chemistry; 2017 Dec; 23(70):17721-17726. PubMed ID: 28758266 [TBL] [Abstract][Full Text] [Related]
32. Involvement of TLR7 and TLR8 in conceptus development and establishment of pregnancy in sheep. Ruiz-González I; Minten M; Wang X; Dunlap KA; Bazer FW Reproduction; 2015 Apr; 149(4):305-16. PubMed ID: 25602033 [TBL] [Abstract][Full Text] [Related]
33. Novel and Selective TLR7 Antagonists among the Imidazo[1,2- Bou Karroum N; Moarbess G; Guichou JF; Bonnet PA; Patinote C; Bouharoun-Tayoun H; Chamat S; Cuq P; Diab-Assaf M; Kassab I; Deleuze-Masquefa C J Med Chem; 2019 Aug; 62(15):7015-7031. PubMed ID: 31283223 [TBL] [Abstract][Full Text] [Related]
34. Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity. Beesu M; Caruso G; Salyer AC; Khetani KK; Sil D; Weerasinghe M; Tanji H; Ohto U; Shimizu T; David SA J Med Chem; 2015 Oct; 58(19):7833-49. PubMed ID: 26351878 [TBL] [Abstract][Full Text] [Related]
35. Identification, characterization and genetic mapping of TLR7, TLR8a1 and TLR8a2 genes in rainbow trout (Oncorhynchus mykiss). Palti Y; Gahr SA; Purcell MK; Hadidi S; Rexroad CE; Wiens GD Dev Comp Immunol; 2010 Feb; 34(2):219-33. PubMed ID: 19825389 [TBL] [Abstract][Full Text] [Related]
36. [Structural Analyses of Toll-like Receptor Sensing Single-stranded Nucleic Acids and Its Application]. Shimizu T Yakugaku Zasshi; 2016; 136(2):173-8. PubMed ID: 26831789 [TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9. Kandimalla ER; Bhagat L; Wang D; Yu D; Sullivan T; La Monica N; Agrawal S Nucleic Acids Res; 2013 Apr; 41(6):3947-61. PubMed ID: 23396449 [TBL] [Abstract][Full Text] [Related]
38. [Toll-like receptor 8: the awkward TLR]. Alexopoulou L; Desnues B; Demaria O Med Sci (Paris); 2012 Jan; 28(1):96-102. PubMed ID: 22289837 [TBL] [Abstract][Full Text] [Related]
39. Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8. Wang X; Chen Y; Zhang S; Deng JN PLoS One; 2022; 17(4):e0260565. PubMed ID: 35452465 [TBL] [Abstract][Full Text] [Related]
40. Insights on the mechanism of action of immunostimulants in relation to their pharmacological potency. The effects of imidazoquinolines on TLR8. Kubli-Garfias C; Vázquez-Ramírez R; Trejo-Muñoz C; Berber A PLoS One; 2017; 12(6):e0178846. PubMed ID: 28582454 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]